27995969|t|Biliary Phospholipids Sustain Enterocyte Proliferation and Intestinal Tumor Progression via Nuclear Receptor Lrh1 in mice
27995969|a|The proliferative- crypt compartment of the intestinal epithelium is enriched in phospholipids and accumulation of phospholipids has been described in colorectal tumors. Here we hypothesize that biliary phospholipid flow could directly contribute to the proliferative power of normal and dysplastic enterocytes. We used Abcb4 (-/-) mice which lack biliary phospholipid secretion. We first show that Abcb4 (-/-) mice are protected against intestinal tumorigenesis. At the molecular level, the transcriptional activity of the nuclear receptor Liver Receptor Homolog-1 (Lrh1) is reduced in Abcb4 (-/-) mice and its re-activation re-establishes a tumor burden comparable to control mice. Feeding Abcb4 (-/-) mice a diet supplemented with phospholipids completely overcomes the intestinal tumor protective phenotype, thus corroborating the hypothesis that the absence of biliary phospholipids and not lack of Abcb4 gene per se is responsible for the protection. In turn, phospholipids cannot re-establish intestinal tumorigenesis in Abcb4 (-/-) mice crossed with mice with intestinal specific ablation of Lrh1, a nuclear hormone receptor that is activates by phospholipids. Our data identify the key role of biliary phospholipids in sustaining intestinal mucosa proliferation and tumor progression through the activation of nuclear receptor Lrh1.
27995969	0	7	Biliary	T023	C0005423
27995969	8	21	Phospholipids	T109,T123	C0031676
27995969	22	29	Sustain	T169	C0443318
27995969	30	40	Enterocyte	T025	C0682610
27995969	41	54	Proliferation	T043	C0596290
27995969	59	75	Intestinal Tumor	T191	C0021841
27995969	76	87	Progression	T191	C0178874
27995969	92	108	Nuclear Receptor	T116,T192	C0206588
27995969	109	113	Lrh1	T116,T192	C1448055
27995969	117	121	mice	T015	C0025929
27995969	141	158	crypt compartment	T023	C3686613
27995969	166	187	intestinal epithelium	T024	C0226890
27995969	203	216	phospholipids	T109,T123	C0031676
27995969	221	233	accumulation	T033	C4055506
27995969	237	250	phospholipids	T109,T123	C0031676
27995969	273	290	colorectal tumors	T191	C0009404
27995969	317	324	biliary	T023	C0005423
27995969	325	337	phospholipid	T109,T123	C0031676
27995969	338	342	flow	T070	C0806140
27995969	376	395	proliferative power	T169	C1514485
27995969	399	405	normal	T025	C0682610
27995969	410	432	dysplastic enterocytes	T025	C1512101
27995969	442	447	Abcb4	T028	C1412071
27995969	454	458	mice	T015	C0025929
27995969	470	477	biliary	T023	C0005423
27995969	478	490	phospholipid	T109,T123	C0031676
27995969	491	500	secretion	T038	C0036536
27995969	521	526	Abcb4	T028	C1412071
27995969	533	537	mice	T015	C0025929
27995969	542	551	protected	T033	C1545588
27995969	560	570	intestinal	T023	C0021853
27995969	571	584	tumorigenesis	T191	C0007621
27995969	593	602	molecular	T080	C1521991
27995969	603	608	level	T080	C0441889
27995969	614	638	transcriptional activity	T045	C1148759
27995969	646	662	nuclear receptor	T116,T192	C0206588
27995969	663	687	Liver Receptor Homolog-1	T116,T192	C1448055
27995969	689	693	Lrh1	T116,T192	C1448055
27995969	698	705	reduced	T080	C0392756
27995969	709	714	Abcb4	T028	C1412071
27995969	721	725	mice	T015	C0025929
27995969	734	747	re-activation	T052	C4086768
27995969	765	770	tumor	T191	C0027651
27995969	771	777	burden	T078	C2828008
27995969	792	799	control	T096	C0009932
27995969	800	804	mice	T015	C0025929
27995969	806	813	Feeding	T052	C2987508
27995969	814	819	Abcb4	T028	C1412071
27995969	826	830	mice	T015	C0025929
27995969	833	850	diet supplemented	T168	C0242295
27995969	856	869	phospholipids	T109,T123	C0031676
27995969	881	890	overcomes	T052	C2983310
27995969	895	911	intestinal tumor	T191	C0021841
27995969	923	932	phenotype	T032	C0031437
27995969	977	984	absence	T169	C0332197
27995969	988	995	biliary	T023	C0005423
27995969	996	1009	phospholipids	T109,T123	C0031676
27995969	1026	1036	Abcb4 gene	T028	C1412071
27995969	1067	1077	protection	T033	C1545588
27995969	1088	1101	phospholipids	T109,T123	C0031676
27995969	1122	1132	intestinal	T023	C0021853
27995969	1133	1146	tumorigenesis	T191	C0007621
27995969	1150	1155	Abcb4	T028	C1412071
27995969	1162	1166	mice	T015	C0025929
27995969	1180	1184	mice	T015	C0025929
27995969	1190	1200	intestinal	T023	C0021853
27995969	1201	1209	specific	T080	C0205369
27995969	1210	1218	ablation	T061	C0547070
27995969	1222	1226	Lrh1	T116,T192	C1448055
27995969	1230	1254	nuclear hormone receptor	T116,T192	C0887829
27995969	1263	1272	activates	T052	C1879547
27995969	1276	1289	phospholipids	T109,T123	C0031676
27995969	1295	1299	data	T078	C1511726
27995969	1325	1332	biliary	T023	C0005423
27995969	1333	1346	phospholipids	T109,T123	C0031676
27995969	1361	1378	intestinal mucosa	T024	C0021839
27995969	1379	1392	proliferation	T169	C1514485
27995969	1397	1414	tumor progression	T191	C0178874
27995969	1427	1437	activation	T052	C1879547
27995969	1441	1457	nuclear receptor	T116,T192	C0206588
27995969	1458	1462	Lrh1	T116,T192	C1448055